nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Urethral disorder—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Cefuroxime—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Cefuroxime—Anorexia—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Cefuroxime—Skin disorder—Gemcitabine—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Cefuroxime—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Cefuroxime—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Cefuroxime—Dizziness—Tamoxifen—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Cefuroxime—Tachycardia—Fluorouracil—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Cefuroxime—Anorexia—Gemcitabine—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Dizziness—Erlotinib—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Renal impairment—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Cefuroxime—Erythema multiforme—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Cefuroxime—Anorexia—Fluorouracil—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Cefuroxime—Vomiting—Tamoxifen—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefuroxime—Hypersensitivity—Sunitinib—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefuroxime—Rash—Tamoxifen—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Cefuroxime—Dermatitis—Tamoxifen—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Vomiting—Erlotinib—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Dyspnoea—Irinotecan—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Somnolence—Irinotecan—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Headache—Tamoxifen—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Cefuroxime—Rash—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Dermatitis—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Angiopathy—Docetaxel—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Dyspepsia—Irinotecan—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Immune system disorder—Docetaxel—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Headache—Erlotinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Cefuroxime—Chills—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Decreased appetite—Irinotecan—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Dyspnoea—Gemcitabine—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Somnolence—Gemcitabine—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Pruritus—Sunitinib—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Pain—Irinotecan—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Dyspnoea—Fluorouracil—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Somnolence—Fluorouracil—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Erythema—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Decreased appetite—Gemcitabine—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Dyspepsia—Fluorouracil—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefuroxime—Nausea—Tamoxifen—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Cefuroxime—Pain—Gemcitabine—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefuroxime—Nausea—Erlotinib—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefuroxime—Decreased appetite—Fluorouracil—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefuroxime—Diarrhoea—Sunitinib—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Cefuroxime—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Cefuroxime—Pain—Fluorouracil—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Cefuroxime—Muscle spasms—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Cefuroxime—Eosinophilia—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Cefuroxime—Dizziness—Sunitinib—pancreatic cancer	0.001	0.001	CcSEcCtD
Cefuroxime—Body temperature increased—Irinotecan—pancreatic cancer	0.000987	0.000987	CcSEcCtD
Cefuroxime—Abdominal pain—Irinotecan—pancreatic cancer	0.000987	0.000987	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000987	0.000987	CcSEcCtD
Cefuroxime—Bronchitis—Epirubicin—pancreatic cancer	0.000984	0.000984	CcSEcCtD
Cefuroxime—Pancytopenia—Epirubicin—pancreatic cancer	0.000972	0.000972	CcSEcCtD
Cefuroxime—Vomiting—Sunitinib—pancreatic cancer	0.000963	0.000963	CcSEcCtD
Cefuroxime—Body temperature increased—Gemcitabine—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Cefuroxime—Dysuria—Epirubicin—pancreatic cancer	0.000957	0.000957	CcSEcCtD
Cefuroxime—Neutropenia—Epirubicin—pancreatic cancer	0.000957	0.000957	CcSEcCtD
Cefuroxime—Rash—Sunitinib—pancreatic cancer	0.000955	0.000955	CcSEcCtD
Cefuroxime—Dermatitis—Sunitinib—pancreatic cancer	0.000955	0.000955	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000951	0.000951	CcSEcCtD
Cefuroxime—Urticaria—Fluorouracil—pancreatic cancer	0.00095	0.00095	CcSEcCtD
Cefuroxime—Headache—Sunitinib—pancreatic cancer	0.000949	0.000949	CcSEcCtD
Cefuroxime—Leukopenia—Docetaxel—pancreatic cancer	0.000946	0.000946	CcSEcCtD
Cefuroxime—Body temperature increased—Fluorouracil—pancreatic cancer	0.000945	0.000945	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—pancreatic cancer	0.000938	0.000938	CcSEcCtD
Cefuroxime—Palpitations—Docetaxel—pancreatic cancer	0.000934	0.000934	CcSEcCtD
Cefuroxime—Cough—Docetaxel—pancreatic cancer	0.000923	0.000923	CcSEcCtD
Cefuroxime—Hypersensitivity—Irinotecan—pancreatic cancer	0.00092	0.00092	CcSEcCtD
Cefuroxime—Convulsion—Docetaxel—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Cefuroxime—Infestation—Epirubicin—pancreatic cancer	0.000912	0.000912	CcSEcCtD
Cefuroxime—Infestation NOS—Epirubicin—pancreatic cancer	0.000912	0.000912	CcSEcCtD
Cefuroxime—Drowsiness—Epirubicin—pancreatic cancer	0.000912	0.000912	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000905	0.000905	CcSEcCtD
Cefuroxime—Arthralgia—Docetaxel—pancreatic cancer	0.0009	0.0009	CcSEcCtD
Cefuroxime—Chest pain—Docetaxel—pancreatic cancer	0.0009	0.0009	CcSEcCtD
Cefuroxime—Nausea—Sunitinib—pancreatic cancer	0.0009	0.0009	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—pancreatic cancer	0.000899	0.000899	CcSEcCtD
Cefuroxime—Renal failure—Epirubicin—pancreatic cancer	0.000897	0.000897	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000894	0.000894	CcSEcCtD
Cefuroxime—Jaundice—Epirubicin—pancreatic cancer	0.000889	0.000889	CcSEcCtD
Cefuroxime—Stomatitis—Epirubicin—pancreatic cancer	0.000889	0.000889	CcSEcCtD
Cefuroxime—Urinary tract infection—Epirubicin—pancreatic cancer	0.000887	0.000887	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—pancreatic cancer	0.000885	0.000885	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—pancreatic cancer	0.000885	0.000885	CcSEcCtD
Cefuroxime—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000881	0.000881	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00088	0.00088	CcSEcCtD
Cefuroxime—Sweating—Epirubicin—pancreatic cancer	0.000875	0.000875	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Cefuroxime—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Cefuroxime—Pruritus—Gemcitabine—pancreatic cancer	0.00086	0.00086	CcSEcCtD
Cefuroxime—Sinusitis—Epirubicin—pancreatic cancer	0.000856	0.000856	CcSEcCtD
Cefuroxime—Diarrhoea—Irinotecan—pancreatic cancer	0.000854	0.000854	CcSEcCtD
Cefuroxime—Agranulocytosis—Epirubicin—pancreatic cancer	0.000852	0.000852	CcSEcCtD
Cefuroxime—Pruritus—Fluorouracil—pancreatic cancer	0.000846	0.000846	CcSEcCtD
Cefuroxime—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000845	0.000845	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—pancreatic cancer	0.000844	0.000844	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—pancreatic cancer	0.000844	0.000844	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—pancreatic cancer	0.000844	0.000844	CcSEcCtD
Cefuroxime—Tachycardia—Docetaxel—pancreatic cancer	0.000842	0.000842	CcSEcCtD
Cefuroxime—Skin disorder—Docetaxel—pancreatic cancer	0.000838	0.000838	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000837	0.000837	CcSEcCtD
Cefuroxime—Diarrhoea—Gemcitabine—pancreatic cancer	0.000832	0.000832	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—pancreatic cancer	0.00083	0.00083	CcSEcCtD
Cefuroxime—Dizziness—Irinotecan—pancreatic cancer	0.000825	0.000825	CcSEcCtD
Cefuroxime—Haemoglobin—Epirubicin—pancreatic cancer	0.000823	0.000823	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—pancreatic cancer	0.000823	0.000823	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—pancreatic cancer	0.000823	0.000823	CcSEcCtD
Cefuroxime—Anorexia—Docetaxel—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000821	0.000821	CcSEcCtD
Cefuroxime—Haemorrhage—Epirubicin—pancreatic cancer	0.000819	0.000819	CcSEcCtD
Cefuroxime—Hepatitis—Epirubicin—pancreatic cancer	0.000819	0.000819	CcSEcCtD
Cefuroxime—Diarrhoea—Fluorouracil—pancreatic cancer	0.000818	0.000818	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—pancreatic cancer	0.000809	0.000809	CcSEcCtD
Cefuroxime—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000809	0.000809	CcSEcCtD
Cefuroxime—Urethral disorder—Epirubicin—pancreatic cancer	0.000803	0.000803	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000798	0.000798	CcSEcCtD
Cefuroxime—Vomiting—Irinotecan—pancreatic cancer	0.000794	0.000794	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—pancreatic cancer	0.000792	0.000792	CcSEcCtD
Cefuroxime—Dizziness—Fluorouracil—pancreatic cancer	0.000791	0.000791	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000788	0.000788	CcSEcCtD
Cefuroxime—Rash—Irinotecan—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Cefuroxime—Dermatitis—Irinotecan—pancreatic cancer	0.000786	0.000786	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000786	0.000786	CcSEcCtD
Cefuroxime—Headache—Irinotecan—pancreatic cancer	0.000782	0.000782	CcSEcCtD
Cefuroxime—Erythema multiforme—Epirubicin—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Cefuroxime—Vomiting—Gemcitabine—pancreatic cancer	0.000773	0.000773	CcSEcCtD
Cefuroxime—Dyspnoea—Docetaxel—pancreatic cancer	0.000769	0.000769	CcSEcCtD
Cefuroxime—Somnolence—Docetaxel—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Cefuroxime—Rash—Gemcitabine—pancreatic cancer	0.000767	0.000767	CcSEcCtD
Cefuroxime—Dermatitis—Gemcitabine—pancreatic cancer	0.000766	0.000766	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Cefuroxime—Headache—Gemcitabine—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Cefuroxime—Vomiting—Fluorouracil—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Cefuroxime—Dyspepsia—Docetaxel—pancreatic cancer	0.000759	0.000759	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—pancreatic cancer	0.000758	0.000758	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—pancreatic cancer	0.000758	0.000758	CcSEcCtD
Cefuroxime—Rash—Fluorouracil—pancreatic cancer	0.000754	0.000754	CcSEcCtD
Cefuroxime—Dermatitis—Fluorouracil—pancreatic cancer	0.000753	0.000753	CcSEcCtD
Cefuroxime—Decreased appetite—Docetaxel—pancreatic cancer	0.00075	0.00075	CcSEcCtD
Cefuroxime—Headache—Fluorouracil—pancreatic cancer	0.000749	0.000749	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000748	0.000748	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000745	0.000745	CcSEcCtD
Cefuroxime—Angiopathy—Epirubicin—pancreatic cancer	0.000743	0.000743	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—pancreatic cancer	0.000743	0.000743	CcSEcCtD
Cefuroxime—Nausea—Irinotecan—pancreatic cancer	0.000741	0.000741	CcSEcCtD
Cefuroxime—Immune system disorder—Epirubicin—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Cefuroxime—Pain—Docetaxel—pancreatic cancer	0.000738	0.000738	CcSEcCtD
Cefuroxime—Chills—Epirubicin—pancreatic cancer	0.000735	0.000735	CcSEcCtD
Cefuroxime—Nausea—Gemcitabine—pancreatic cancer	0.000722	0.000722	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Cefuroxime—Erythema—Epirubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Cefuroxime—Nausea—Fluorouracil—pancreatic cancer	0.00071	0.00071	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Cefuroxime—Flatulence—Epirubicin—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—pancreatic cancer	0.000688	0.000688	CcSEcCtD
Cefuroxime—Muscle spasms—Epirubicin—pancreatic cancer	0.000686	0.000686	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—pancreatic cancer	0.000685	0.000685	CcSEcCtD
Cefuroxime—Body temperature increased—Docetaxel—pancreatic cancer	0.000682	0.000682	CcSEcCtD
Cefuroxime—Abdominal pain—Docetaxel—pancreatic cancer	0.000682	0.000682	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—pancreatic cancer	0.00068	0.00068	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Cefuroxime—Agitation—Epirubicin—pancreatic cancer	0.000655	0.000655	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—pancreatic cancer	0.00065	0.00065	CcSEcCtD
Cefuroxime—Leukopenia—Epirubicin—pancreatic cancer	0.000638	0.000638	CcSEcCtD
Cefuroxime—Hypersensitivity—Docetaxel—pancreatic cancer	0.000636	0.000636	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—pancreatic cancer	0.000634	0.000634	CcSEcCtD
Cefuroxime—Palpitations—Epirubicin—pancreatic cancer	0.00063	0.00063	CcSEcCtD
Cefuroxime—Cough—Epirubicin—pancreatic cancer	0.000622	0.000622	CcSEcCtD
Cefuroxime—Convulsion—Epirubicin—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Cefuroxime—Pruritus—Docetaxel—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Cefuroxime—Chest pain—Epirubicin—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Cefuroxime—Arthralgia—Epirubicin—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—pancreatic cancer	0.000606	0.000606	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000603	0.000603	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Cefuroxime—Diarrhoea—Docetaxel—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—pancreatic cancer	0.000583	0.000583	CcSEcCtD
Cefuroxime—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000582	0.000582	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—pancreatic cancer	0.000572	0.000572	CcSEcCtD
Cefuroxime—Dizziness—Docetaxel—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Cefuroxime—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Cefuroxime—Tachycardia—Epirubicin—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Cefuroxime—Skin disorder—Epirubicin—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Cefuroxime—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000563	0.000563	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Cefuroxime—Anorexia—Epirubicin—pancreatic cancer	0.000555	0.000555	CcSEcCtD
Cefuroxime—Vomiting—Docetaxel—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Cefuroxime—Rash—Docetaxel—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Cefuroxime—Dermatitis—Docetaxel—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Cefuroxime—Headache—Docetaxel—pancreatic cancer	0.000541	0.000541	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000538	0.000538	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000527	0.000527	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—pancreatic cancer	0.000526	0.000526	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000521	0.000521	CcSEcCtD
Cefuroxime—Dyspnoea—Epirubicin—pancreatic cancer	0.000519	0.000519	CcSEcCtD
Cefuroxime—Somnolence—Epirubicin—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—pancreatic cancer	0.000513	0.000513	CcSEcCtD
Cefuroxime—Nausea—Docetaxel—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Cefuroxime—Dyspepsia—Epirubicin—pancreatic cancer	0.000512	0.000512	CcSEcCtD
Cefuroxime—Decreased appetite—Epirubicin—pancreatic cancer	0.000506	0.000506	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000502	0.000502	CcSEcCtD
Cefuroxime—Pain—Epirubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000491	0.000491	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—pancreatic cancer	0.000468	0.000468	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Cefuroxime—Urticaria—Epirubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Cefuroxime—Body temperature increased—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Cefuroxime—Abdominal pain—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Cefuroxime—Hypersensitivity—Epirubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—pancreatic cancer	0.000428	0.000428	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Cefuroxime—Pruritus—Epirubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Cefuroxime—Diarrhoea—Epirubicin—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Cefuroxime—Dizziness—Epirubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Cefuroxime—Vomiting—Epirubicin—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—pancreatic cancer	0.000368	0.000368	CcSEcCtD
Cefuroxime—Rash—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Cefuroxime—Dermatitis—Epirubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Cefuroxime—Headache—Epirubicin—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Cefuroxime—Nausea—Epirubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—pancreatic cancer	0.000342	0.000342	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—pancreatic cancer	0.000339	0.000339	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—pancreatic cancer	0.000337	0.000337	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—pancreatic cancer	0.00032	0.00032	CcSEcCtD
